Determining colorectal cancer features using a Rwandan population to lay a foundation and inform precise colorectal cancer clinical management

Not Applicable

• Conditions: Colorectal cancer; Cancer

• Registration Number: ISRCTN36459506
• Lead Sponsor: KU Leuven

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-12-24
• Last Update Posted: 4 January 2022
• Study Completion: 2022-07-29

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

1. Histologically confirmed colorectal cancer
2. Diagnosis made or reviewed at King Faisal Hospital (KFH) between 01/01/2019 and 29/02/2021, or prospectively from 21/03/2021 to 31/05/2021
3. Adult

Exclusion Criteria

Patients with colorectal masses that are not histologically confirmed

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
MSI status, categorised as MSI-H, MSI-L, or MSS, measured using Promega (MSI Analysis System, Version 1.2) kit at a single time point